Shield Therapeutics Share Discussion Threads

[purchaseatthetop] 24/6/2021 14:40

Ohojim....well spotted. I actually envisaged a box of chocolates as I wrote that drivel!

[oapknob1] 24/6/2021 14:08

Watch SHIEF pre market

[eastlands] 24/6/2021 14:06

Some big 100k block buys popping up now

[babbler] 24/6/2021 13:57

Yes to USA investors who actually get the opportunity here. Unlike UK traders in for 3%

[bl219] 24/6/2021 13:18

There's another share that I REALLY like and I considered selling here to buy yet more in that but I genuinely just cannot bring myself to do it. Wider market considerations aside, I cannot see this doing anything other than heading north over the next year or more and definitely feel that PATT's latest comment - although tongue in cheek - is spot on. I guess this is the real definition of being "comfortable" with a share. But hey! DYOR.

[purchaseatthetop] 24/6/2021 12:50

Roger you are missing many years of failed projects, terrible diligence errors, raised capital and shareholder tears.

Now a beautiful swan has appeared sailing serenely down bubbling brooks with banks of tender flowers.

[bl219] 24/6/2021 12:48

Greg is on 2nd at 4pm this afternoon.

Me and Greg are on first name terms......evidently :-)

[78steve] 24/6/2021 12:38

Roger. How do you value a company such as this. I suppose once they get some visibilty of sales figures market will be in a position to value it based on that.

[rogerrail] 24/6/2021 12:20

Is this only worth £125m ? What am I missing?

[napoleon 14th] 24/6/2021 12:07

LM - not just imagined;
Greg Madison, C E O, will present at the OTCQX Life Science Virtual Investor Forum at 3.00pm BST , Thursday, 24 June 2021.

[little minx] 24/6/2021 11:58

Did I imagine STX were doing a presentation somewhere this afternoon?

[maytrees] 24/6/2021 11:36

Ahh bid share price now reduced to 56.40p - predictable I suppose.

[maytrees] 24/6/2021 11:35

Added again at 57p - the published bid share price

[goblin99] 24/6/2021 11:24

A bit pointless... So you completely ignore the published articles/papers that contradict your findings. Why not post a link to your articles highlighting the cost savings... I'm sure we and potential new investors would find it useful. After all, one can not argue with hard numbers.

[maytrees] 24/6/2021 11:15

Odd that my small buy of 1000 shares just now was at the sell share price of 57p

[purchaseatthetop] 24/6/2021 11:11

I guess the argument is a bit pointless....it depends. I looked at my figures and I am sure there are many other figure out there.

What is sure is that unless the is a medical reason, patients and insurance companies would much prefer accrufer.

[goblin99] 24/6/2021 11:10

And pages 6-8 of this report from 2018:http://ntag.nhs.uk/docs/app/NTAG-Appraisal-Ferric-Maltol-for-IDA-license-extension-final-for-web.pdf

[goblin99] 24/6/2021 11:07

Not the paper in question, but gives an indication of cost savings when compared to IV treatment. https://www.prnewswire.com/news-releases/new-data-show-oral-ferric-maltol-feraccru-may-be-a-cost-effective-alternative-to-intravenous-iv-carboxymaltose-with-at-least-as-great-benefits-in-the-quality-of-life-of-patients-with-iron-deficiency-anaemia-and-inflammatory-b-301006469.html

[death by donut] 24/6/2021 10:26

Quite correct I expect , my IV infusions (IBD Biologic) started out at1st dose2nd 2 weekly3rd 4 weekly4th 8 weekly and continue at that interval.As I recall if treatment is stopped , once 16 weeks has passed , should the need arise to restart , it goes back to beginning.May be different for Accrufer , I don't know , but probably comes down to trough scores?DbD :-)

[frrinvest] 24/6/2021 10:26

Accrufer not only wins on costs but other benefits too - of administering from home versus going to hospital especially in the Covid-19 pandemic which is here to stay for a long time it appears. A win win.

On a separate note, the Chinese is a big market too (probably even bigger than USA) and they are currently undergoing their own studies and approval process. Only a matter of time and when it comes through the share price could be on an another level. However, STX may well be a history by then as someone can take it over. Another win win.

Really cheap at this level imho. DYOR!

[goblin99] 24/6/2021 10:20

Moving on, the next 6 months to a year will dictate the theme in the next few chapters of the story that is Shield therapeutics. Could be an exciting journey, for those that are patient enough to endure the small bumps along the road.

[purchaseatthetop] 24/6/2021 10:18

Well you believe your figures and I will believe mine. Bothers me not.

[goblin99] 24/6/2021 10:17

There is a research note out somewhere, can not remember where it is, detailing the comparative costs of the two. The disparity is nowhere near your estimates.